# A Study of HS-10518 in Healthy Female Participants

> **NCT06118827** · PHASE1 · UNKNOWN · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 48 (estimated)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** HS-10518
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06118827
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-01
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06118827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06118827, "A Study of HS-10518 in Healthy Female Participants". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06118827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*